1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. Early 2 Factor (E2F)

Early 2 Factor (E2F) 

The Early 2 Factors (E2Fs) are a family of eight winged-helix transcription factors that are key to regulating cell cycle progression from G1 to S phase among other functions. E2F1, E2F2, and E2F3a are expressed in early G1 through S phase and are believed to promote S phase initiation by activating genes involved in the G1 to S phase transition18. E2F3b, E2F4, E2F6, E2F5, E2F7, and E2F8 act as repressors and are expressed later in the cell cycle. E2Fs participate in myriad cell biological processes including: the cell cycle, DNA repair, apoptosis, development, differentiation, and metabolism.

Early 2 Factor (E2F) 相关产品 (3):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-16667
    HLM006474 Inhibitor 99.57%
    HLM006474 是一种广谱的 E2F 抑制剂,在 A375 细胞中,可抑制 E2F4 DNA 结合,IC50 值为 29.8 µM。
    HLM006474
  • HY-117857
    MRT00033659 Inhibitor 99.77%
    MRT00033659 是一种有效的广谱激酶抑制剂,抑制 CK1 (对 CK1δ:IC50=0.9 µM) 和 CHK1 (IC50=0.23 µM)。MRT00033659 是一种吡唑并吡啶类似物,可以诱导 p53 途径活化和 E2F-1 不稳定。
    MRT00033659
  • HY-149209
    LL-K8-22 Inhibitor 99.76%
    LL-K8-22 是一种有效、选择性和持久的 CDK8-cyclin C 双重降解剂,DC50 值分别为 2.52 和 2.64 μM。 LL-K8-22 还抑制 STAT1 Ser 727 磷酸化。 LL-K8-22 抑制 E2F 和 MYC 驱动的致癌转录程序。 LL-K8-22可用于三阴性乳腺癌 (TNBC) 研究。
    LL-K8-22